SCHEMBL7611013

SCHEMBL7611013

CC(=O)OCC(c1ccc(NC(=O)OC(C)(C)C)cc1)c1ccc(NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.46
PTPN11 Q06124 1/20 0.42
PPARG P37231 2/20 0.42
PPARA Q07869 1/20 0.42
PSMB8 P28062 1/20 0.41
NAMPT P43490 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPKAPK2 P49137 1/20 0.39
DRD2 P14416 1/20 0.39
MAPK14 Q16539 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
GLS O94925 1/20 0.39
MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7609839 0.85 SMN1; SMN2 (0.54) NPC1HPGDRAB9ASMN1; SMN2L3MBTL1
SCHEMBL7613210 0.82 CYP17A1 (0.50) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL7605437 0.81 CYP17A1 (0.49) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL13055402 0.78 CYP17A1 (0.59) CYP17A1PTPN11PSMB8NAMPTPTGDR2
SCHEMBL24263030 0.77 CYP17A1 (0.50) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL104556 0.77 RAB9A (0.55) CYP17A1PSMB8NAMPTNPC1HPGD
SCHEMBL1864567 0.77 CYP17A1 (0.50) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL5726217 0.77 NR1H4 (0.57) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL11087230 0.77 NAMPT (0.48) CYP17A1PTPN11PPARGPPARAPSMB8
SCHEMBL1000734 0.77 NR1H4 (0.57) CYP17A1PTPN11PPARGPPARAPSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed